TRASTUZUMAB EMTANSINE for Breast cancer metastatic: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 49 adverse event reports in the FDA FAERS database where TRASTUZUMAB EMTANSINE was used for Breast cancer metastatic.
Most Reported Side Effects for TRASTUZUMAB EMTANSINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 38 | 20.8% | 0 | 26 |
| Disease progression | 20 | 10.9% | 9 | 10 |
| Platelet count decreased | 16 | 8.7% | 1 | 12 |
| Metastases to central nervous system | 11 | 6.0% | 4 | 4 |
| Pneumonia | 7 | 3.8% | 3 | 7 |
| Thrombocytopenia | 7 | 3.8% | 4 | 4 |
| Anaemia | 6 | 3.3% | 1 | 5 |
| Decreased appetite | 6 | 3.3% | 1 | 4 |
| Hepatic function abnormal | 6 | 3.3% | 0 | 4 |
| Aspartate aminotransferase increased | 5 | 2.7% | 0 | 4 |
| Nausea | 5 | 2.7% | 3 | 5 |
| Pyrexia | 5 | 2.7% | 1 | 5 |
Other Indications for TRASTUZUMAB EMTANSINE
Breast cancer (80)
Her-2 positive breast cancer (19)
Her2 positive breast cancer (11)
Neoplasm malignant (5)
Other Drugs Used for Breast cancer metastatic
PALBOCICLIB (18,160)
RIBOCICLIB (9,771)
LETROZOLE (6,856)
TRASTUZUMAB (6,303)
FULVESTRANT (4,570)
PERTUZUMAB (3,784)
CAPECITABINE (3,691)
PACLITAXEL (3,241)
DOCETAXEL (3,070)
EVEROLIMUS (2,751)